Electrical Equipment & Parts
Compare Stocks
5 / 10Stock Comparison
EOSE vs FLUX vs STEM vs NRGV vs CBAT
Revenue, margins, valuation, and 5-year total return — side by side.
Electrical Equipment & Parts
Software - Infrastructure
Renewable Utilities
Electrical Equipment & Parts
EOSE vs FLUX vs STEM vs NRGV vs CBAT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Electrical Equipment & Parts | Electrical Equipment & Parts | Software - Infrastructure | Renewable Utilities | Electrical Equipment & Parts |
| Market Cap | $2.14B | $23M | $74M | $716M | $70M |
| Revenue (TTM) | $114M | $51M | $153M | $217M | $162M |
| Net Income (TTM) | $-1.74B | $-6M | $144M | $-115M | $-7M |
| Gross Margin | -125.9% | 32.1% | 36.3% | 22.1% | 10.8% |
| Operating Margin | -227.0% | -1.9% | -35.1% | -35.8% | -10.5% |
| Forward P/E | — | — | — | — | 6.0x |
| Total Debt | $834M | $16M | $369M | $95M | $30M |
| Cash & Equiv. | $568M | $1M | $49M | $58M | $7M |
EOSE vs FLUX vs STEM vs NRGV vs CBAT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| Eos Energy Enterpri… (EOSE) | 100 | 32.3 | -67.7% |
| Flux Power Holdings… (FLUX) | 100 | 10.0 | -90.0% |
| Stem, Inc. (STEM) | 100 | 1.6 | -98.4% |
| Energy Vault Holdin… (NRGV) | 100 | 42.7 | -57.3% |
| CBAK Energy Technol… (CBAT) | 100 | 15.4 | -84.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EOSE vs FLUX vs STEM vs NRGV vs CBAT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EOSE ranks third and is worth considering specifically for growth exposure and long-term compounding.
- Rev growth 6.3%, EPS growth -47.0%, 3Y rev CAGR 85.4%
- -34.4% 10Y total return vs NRGV's -57.1%
- 6.3% revenue growth vs CBAT's -13.6%
Among these 5 stocks, FLUX doesn't own a clear edge in any measured category.
STEM has the current edge in this matchup, primarily because of its strength in quality and efficiency.
- 94.2% margin vs EOSE's -15.3%
- 43.2% ROA vs EOSE's -197.1%
NRGV is the clearest fit if your priority is momentum.
- +447.1% vs FLUX's -31.9%
CBAT is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 1 yrs, beta 1.05
- Lower volatility, beta 1.05, Low D/E 25.1%, current ratio 0.82x
- Beta 1.05, current ratio 0.82x
- Better valuation composite
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.3% revenue growth vs CBAT's -13.6% | |
| Value | Better valuation composite | |
| Quality / Margins | 94.2% margin vs EOSE's -15.3% | |
| Stability / Safety | Beta 1.05 vs STEM's 3.66 | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +447.1% vs FLUX's -31.9% | |
| Efficiency (ROA) | 43.2% ROA vs EOSE's -197.1% |
EOSE vs FLUX vs STEM vs NRGV vs CBAT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
EOSE vs FLUX vs STEM vs NRGV vs CBAT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CBAT leads in 2 of 6 categories
EOSE leads 1 • FLUX leads 0 • STEM leads 0 • NRGV leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — EOSE and STEM each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NRGV is the larger business by revenue, generating $217M annually — 4.3x FLUX's $51M. STEM is the more profitable business, keeping 94.2% of every revenue dollar as net income compared to EOSE's -15.3%. On growth, EOSE holds the edge at +7.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $114M | $51M | $153M | $217M | $162M |
| EBITDAEarnings before interest/tax | -$259M | -$212,000 | -$16M | -$72M | -$8M |
| Net IncomeAfter-tax profit | -$1.7B | -$6M | $144M | -$115M | -$7M |
| Free Cash FlowCash after capex | -$265M | -$7M | -$8M | -$98M | -$8M |
| Gross MarginGross profit ÷ Revenue | -125.9% | +32.1% | +36.3% | +22.1% | +10.8% |
| Operating MarginEBIT ÷ Revenue | -2.3% | -1.9% | -35.1% | -35.8% | -10.5% |
| Net MarginNet income ÷ Revenue | -15.3% | -12.5% | +94.2% | -53.0% | -4.0% |
| FCF MarginFCF ÷ Revenue | -2.3% | -14.7% | -5.5% | -45.2% | -5.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.0% | -60.6% | -10.8% | +156.4% | +36.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +76.1% | -25.0% | +27.2% | -42.9% | — |
Valuation Metrics
CBAT leads this category, winning 2 of 4 comparable metrics.
Valuation Metrics
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.1B | $23M | $74M | $716M | $70M |
| Enterprise ValueMkt cap + debt − cash | $2.4B | $37M | $394M | $752M | $94M |
| Trailing P/EPrice ÷ TTM EPS | -0.95x | -3.25x | -0.95x | -6.37x | 6.04x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | — | — | 5.22x |
| Price / SalesMarket cap ÷ Revenue | 18.77x | 0.34x | 0.48x | 3.52x | 0.40x |
| Price / BookPrice ÷ Book value/share | — | — | — | 7.50x | 0.59x |
| Price / FCFMarket cap ÷ FCF | — | — | 10.82x | — | 3.13x |
Profitability & Efficiency
CBAT leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
CBAT delivers a -5.5% return on equity — every $100 of shareholder capital generates $-6 in annual profit, vs $-7 for FLUX. CBAT carries lower financial leverage with a 0.25x debt-to-equity ratio, signaling a more conservative balance sheet compared to NRGV's 1.07x. On the Piotroski fundamental quality scale (0–9), CBAT scores 7/9 vs NRGV's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | — | -7.4% | — | -146.8% | -5.5% |
| ROA (TTM)Return on assets | -197.1% | -21.0% | +43.2% | -40.3% | -2.0% |
| ROICReturn on invested capital | — | -30.1% | -57.1% | -49.5% | +4.6% |
| ROCEReturn on capital employed | -55.3% | — | -23.9% | -53.7% | +7.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 6 | 4 | 7 |
| Debt / EquityFinancial leverage | — | — | — | 1.07x | 0.25x |
| Net DebtTotal debt minus cash | $266M | $15M | $320M | $36M | $23M |
| Cash & Equiv.Liquid assets | $568M | $1M | $49M | $58M | $7M |
| Total DebtShort + long-term debt | $834M | $16M | $369M | $95M | $30M |
| Interest CoverageEBIT ÷ Interest expense | — | -2.64x | 14.43x | -10.33x | -24.86x |
Total Returns (Dividends Reinvested)
EOSE leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in EOSE five years ago would be worth $5,550 today (with dividends reinvested), compared to $217 for STEM. Over the past 12 months, NRGV leads with a +447.1% total return vs FLUX's -31.9%. The 3-year compound annual growth rate (CAGR) favors EOSE at 49.1% vs STEM's -52.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -51.0% | -8.5% | -48.6% | -15.3% | -8.7% |
| 1-Year ReturnPast 12 months | -4.6% | -31.9% | -16.2% | +447.1% | -6.9% |
| 3-Year ReturnCumulative with dividends | +231.3% | -66.1% | -89.5% | +140.7% | +2.0% |
| 5-Year ReturnCumulative with dividends | -44.5% | -86.4% | -97.8% | -57.7% | -81.0% |
| 10-Year ReturnCumulative with dividends | -34.4% | -69.0% | -95.5% | -57.1% | -69.9% |
| CAGR (3Y)Annualised 3-year return | +49.1% | -30.3% | -52.9% | +34.0% | +0.7% |
Risk & Volatility
Evenly matched — NRGV and CBAT each lead in 1 of 2 comparable metrics.
Risk & Volatility
CBAT is the less volatile stock with a 1.05 beta — it tends to amplify market swings less than STEM's 3.66 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NRGV currently trades 65.2% from its 52-week high vs FLUX's 17.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.23x | 2.30x | 3.66x | 3.08x | 1.05x |
| 52-Week HighHighest price in past year | $19.86 | $7.55 | $32.23 | $6.35 | $1.25 |
| 52-Week LowLowest price in past year | $3.69 | $0.97 | $5.93 | $0.65 | $0.77 |
| % of 52W HighCurrent price vs 52-week peak | +32.0% | +17.2% | +27.0% | +65.2% | +62.8% |
| RSI (14)Momentum oscillator 0–100 | 50.0 | 57.8 | 51.2 | 53.3 | 39.6 |
| Avg Volume (50D)Average daily shares traded | 26.0M | 114K | 155K | 3.7M | 111K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: EOSE as "Hold", STEM as "Hold", NRGV as "Buy". Consensus price targets imply 137.2% upside for STEM (target: $21) vs -33.6% for NRGV (target: $3).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | — | Hold | Buy | — |
| Price TargetConsensus 12-month target | $12.50 | — | $20.67 | $2.75 | — |
| # AnalystsCovering analysts | 10 | — | 17 | 7 | — |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | — | — | 1 |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
CBAT leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). EOSE leads in 1 (Total Returns). 2 tied.
EOSE vs FLUX vs STEM vs NRGV vs CBAT: Key Questions Answered
8 questions · data-driven answers · updated daily
01Is EOSE or FLUX or STEM or NRGV or CBAT a better buy right now?
For growth investors, Eos Energy Enterprises, Inc.
(EOSE) is the stronger pick with 631. 8% revenue growth year-over-year, versus -13. 6% for CBAK Energy Technology, Inc. (CBAT). CBAK Energy Technology, Inc. (CBAT) offers the better valuation at 6. 0x trailing P/E, making it the more compelling value choice. Analysts rate Energy Vault Holdings, Inc. (NRGV) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — EOSE or FLUX or STEM or NRGV or CBAT?
Over the past 5 years, Eos Energy Enterprises, Inc.
(EOSE) delivered a total return of -44. 5%, compared to -97. 8% for Stem, Inc. (STEM). Over 10 years, the gap is even starker: EOSE returned -34. 4% versus STEM's -95. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — EOSE or FLUX or STEM or NRGV or CBAT?
By beta (market sensitivity over 5 years), CBAK Energy Technology, Inc.
(CBAT) is the lower-risk stock at 1. 05β versus Stem, Inc. 's 3. 66β — meaning STEM is approximately 250% more volatile than CBAT relative to the S&P 500. On balance sheet safety, CBAK Energy Technology, Inc. (CBAT) carries a lower debt/equity ratio of 25% versus 107% for Energy Vault Holdings, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — EOSE or FLUX or STEM or NRGV or CBAT?
By revenue growth (latest reported year), Eos Energy Enterprises, Inc.
(EOSE) is pulling ahead at 631. 8% versus -13. 6% for CBAK Energy Technology, Inc. (CBAT). On earnings-per-share growth, the picture is similar: CBAK Energy Technology, Inc. grew EPS 574. 5% year-over-year, compared to -47. 0% for Eos Energy Enterprises, Inc.. Over a 3-year CAGR, EOSE leads at 85. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — EOSE or FLUX or STEM or NRGV or CBAT?
Stem, Inc.
(STEM) is the more profitable company, earning 88. 2% net margin versus -1527. 8% for Eos Energy Enterprises, Inc. — meaning it keeps 88. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CBAT leads at 5. 0% versus -227. 0% for EOSE. At the gross margin level — before operating expenses — STEM leads at 35. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — EOSE or FLUX or STEM or NRGV or CBAT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is EOSE or FLUX or STEM or NRGV or CBAT better for a retirement portfolio?
For long-horizon retirement investors, CBAK Energy Technology, Inc.
(CBAT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 05)). Stem, Inc. (STEM) carries a higher beta of 3. 66 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CBAT: -69. 9%, STEM: -95. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between EOSE and FLUX and STEM and NRGV and CBAT?
These companies operate in different sectors (EOSE (Industrials) and FLUX (Industrials) and STEM (Technology) and NRGV (Utilities) and CBAT (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: EOSE is a small-cap high-growth stock; FLUX is a small-cap quality compounder stock; STEM is a small-cap quality compounder stock; NRGV is a small-cap high-growth stock; CBAT is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.